Catalyst Pharmaceuticals (CPRX) Shareholder's Equity Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Catalyst Pharmaceuticals | 3.82 Bn | 3.07 Bn | 134.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 41.48% |
| Dec 31, 2025 | 41.27% |
| Sep 30, 2025 | 42.50% |
| Jun 30, 2025 | 50.41% |
| Mar 31, 2025 | 51.45% |
| Dec 31, 2024 | 52.70% |
| Sep 30, 2024 | 53.33% |
| Jun 30, 2024 | 57.26% |
| Mar 31, 2024 | 61.45% |
| Dec 31, 2023 | 50.17% |
| Sep 30, 2023 | 40.32% |
| Jun 30, 2023 | 39.49% |
| Mar 31, 2023 | 34.34% |
| Dec 31, 2022 | 29.98% |
| Sep 30, 2022 | 53.46% |
| Jun 30, 2022 | 47.99% |
| Mar 31, 2022 | 44.38% |
| Dec 31, 2021 | 39.39% |
| Sep 30, 2021 | 35.87% |
| Jun 30, 2021 | 32.47% |
| Mar 31, 2021 | 28.73% |
| Dec 31, 2020 | 25.04% |
| Sep 30, 2020 | 20.89% |
| Jun 30, 2020 | 12.11% |
| Mar 31, 2020 | 8.39% |
| Dec 31, 2019 | 19.98% |
| Sep 30, 2019 | 16.32% |
| Jun 30, 2019 | 8.97% |
| Mar 31, 2019 | 23.74% |
| Dec 31, 2018 | 18.88% |
| Sep 30, 2018 | 23.70% |
| Jun 30, 2018 | 48.49% |
| Dec 31, 2017 | 40.82% |
| Mar 31, 2017 | 66.82% |
| Dec 31, 2016 | 59.90% |
| Sep 30, 2016 | 61.75% |
| Jun 30, 2016 | 56.38% |
| Dec 31, 2015 | 58.66% |